EUVIMEDEUVIMED entdecken
Fallbericht

Why Should Orchidopexy Be Performed in Congenital Hypogonadotropic Hypogonadism, and When?

Meriem Bensalah-Hammoutene, Guy Van Vliet

Hormone Research in Paediatrics · 2024

DOI: 10.1159/000530520 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Hormone Research in Paediatrics, 2024. Verfasst von Meriem Bensalah-Hammoutene und 1 weiteren Autor:innen. Beteiligte Einrichtung: Endocrinology Unit, Hôpital Central de l'Armée, Algiers, Algeria. Hauptthemen laut MEDLINE: Cryptorchidism, Hypogonadism, Orchiopexy, Testicular Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 14 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

In otherwise normal boys with undescended testes, early orchidopexy is recommended to preserve fertility, to decrease the risk of testicular cancer, and to facilitate its detection. Indeed, compared to the general population, the risk of testicular cancer is increased two- to eight-fold in isolated cryptorchidism and usually occurs before the age of 40 years. By contrast, when cryptorchidism is associated with congenital hypogonadotropic hypogonadism, the risk of testicular cancer is unknown.

Objective

The aim of this study was to determine the characteristics of testicular cancer when cryptorchidism is associated with congenital hypogonadotropic hypogonadism.

Methods

We conducted a PubMed research without date limits including the following key words: hypogonadism, hypogonadotropic hypogonadism, testicular cancer, testicular germ cell tumors, undescended testis, Kallmann syndrome, FSH, AFP (α foeto protein), βHCG.

Results

Only 3 patients with testicular cancer and congenital hypogonadotropic hypogonadism have been published in the past 4 decades and two were diagnosed at 50 and 64 years.

Conclusion

Gonadotropin deficiency may protect against testicular cancer, and orchidopexy in this context may be deferred.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CryptorchidismHypogonadismOrchiopexyTesticular NeoplasmsAdultHumansMaleMiddle AgedNeoplasms, Germ Cell and Embryonal

Stichwörter der Autor:innen

CryptorchidismGonadotropinsKallmann syndromeTesticular germ cell tumors

Autor:innen und Institutionen

  • Endocrinology Unit, Hôpital Central de l'Armée, Algiers, Algeria.
  • Endocrinology Service and Research Center, Centre Hospitalier Universitaire Ste-Justine and Department of Pediatrics, Université de Montréal, Montreal, Québec, Canada.

Zitieren

APA

Bensalah-Hammoutene, M., & Van Vliet, G. (2024). Why Should Orchidopexy Be Performed in Congenital Hypogonadotropic Hypogonadism, and When?. Hormone Research in Paediatrics. https://doi.org/10.1159/000530520

Vancouver

Bensalah-Hammoutene M, Van Vliet G. Why Should Orchidopexy Be Performed in Congenital Hypogonadotropic Hypogonadism, and When?. Hormone Research in Paediatrics. 2024. doi:10.1159/000530520

BibTeX
@article{BensalahHammoutene2024,
  author = {Bensalah-Hammoutene, Meriem and Van Vliet, Guy},
  title = {Why Should Orchidopexy Be Performed in Congenital Hypogonadotropic Hypogonadism, and When?},
  journal = {Hormone Research in Paediatrics},
  year = {2024},
  doi = {10.1159/000530520}
}
Kostenlos starten →